RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000049.xml
PDF herunterladen
Clin Colon Rectal Surg 2025; 38(02): 141-147
DOI: 10.1055/s-0044-1786198
DOI: 10.1055/s-0044-1786198
Review Article
Nonfistulizing Perianal Crohn's Disease
Abstract
Perianal Crohn's disease (CD) includes a wide range of nonfistulizing sequela, including fissures and ulcers, skin tags, anal stricture, and anal cancer. Symptoms related to perianal manifestations of CD are often disabling and have a significant impact on patients' quality of life. They include pain, drainage, bleeding, difficulty with hygiene and may cause secondary difficulties with sexual and defecatory dysfunction. The care of patients with perianal CD requires a thoughtful approach, including detailed history taking, physical examination, and often multidisciplinary care teams to maximize quality of life and ameliorate symptoms.
Publikationsverlauf
Artikel online veröffentlicht:
19. April 2024
© 2024. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Accessed November 5, 2023 at: https://pubmed.ncbi.nlm.nih.gov/467943/
- 2 Peyrin-Biroulet L, Loftus Jr EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Perianal Crohn's disease findings other than fistulas in a population-based cohort. Inflamm Bowel Dis 2012; 18 (01) 43-48
- 3 Griffin N, Acheson AG, Tung P, Sheard C, Glazebrook C, Scholefield JH. Quality of life in patients with chronic anal fissure. Colorectal Dis 2004; 6 (01) 39-44
- 4 Axelsson A, Johansson M, Bock D. et al. Patient-reported QoL in anal cancer survivors 3 and 6 years after treatment-results from the Swedish national ANCA study. Support Care Cancer 2022; 30 (05) 4169-4178
- 5 Sweeney JL, Ritchie JK, Nicholls RJ. Anal fissure in Crohn's disease. Br J Surg 1988; 75 (01) 56-57
- 6 Fleshner PR, Schoetz Jr DJ, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC. Anal fissure in Crohn's disease: a plea for aggressive management. Dis Colon Rectum 1995; 38 (11) 1137-1143
- 7 Figg RE, Church JM. Perineal Crohn's disease: an indicator of poor prognosis and potential proctectomy. Dis Colon Rectum 2009; 52 (04) 646-650
- 8 Pfenninger JL, Zainea GG. Common anorectal conditions. Obstet Gynecol 2001; 98 (06) 1130-1139
- 9 Cracco N, Zinicola R. Sphincterotomy for anal fissure in Crohn's disease: is it dangerous?. Int J Colorectal Dis 2016; 31 (03) 761
- 10 Stringer EE, Nicholson TJ, Armstrong D. Efficacy of topical metronidazole (10 percent) in the treatment of anorectal Crohn's disease. Dis Colon Rectum 2005; 48 (05) 970-974
- 11 Maeda Y, Ng SC, Durdey P. et al; Topical Metronidazole in Perianal Crohn's Study Group. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease. Br J Surg 2010; 97 (09) 1340-1347
- 12 Hart AL, Plamondon S, Kamm MA. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial. Inflamm Bowel Dis 2007; 13 (03) 245-253
- 13 Nanaeva BA, Vardanyan AV, Khalif IL. [Efficiency of tacrolimus therapy for perianal Crohn's disease]. Ter Arkh 2015; 87 (06) 83-87
- 14 Buchmann P, Keighley MRB, Allan RN, Thompson H, Alexander-Williams J. Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am J Surg 1980; 140 (05) 642-644
- 15 Kruis W, Katalinic A, Klugmann T. et al. Predictive factors for an uncomplicated long-term course of Crohn's disease: a retrospective analysis. J Crohn's Colitis 2013; 7 (07) e263-e270
- 16 Siproudhis L, Mortaji A, Mary JY, Juguet F, Bretagne JF, Gosselin M. Anal lesions: any significant prognosis in Crohn's disease?. Eur J Gastroenterol Hepatol 1997; 9 (03) 239-243
- 17 Bouguen G, Siproudhis L, Gizard E. et al. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Clin Gastroenterol Hepatol 2013; 11 (08) 975-81.e1 , 4
- 18 Castaño-Milla C, Chaparro M, Saro C. et al. Effectiveness of adalimumab in perianal fistulas in Crohn's disease patients naive to anti-TNF therapy. J Clin Gastroenterol 2015; 49 (01) 34-40
- 19 Sands BE, Anderson FH, Bernstein CN. et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350 (09) 876-885
- 20 Wasmann KA, de Groof EJ, Stellingwerf ME. et al. Treatment of perianal fistulas in Crohn's disease, seton versus anti-TNF versus surgical closure following anti-TNF [PISA]: a randomised controlled trial. J Crohn's Colitis 2020; 14 (08) 1049-1056
- 21 Bouguen G, Trouilloud I, Siproudhis L. et al. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab. Aliment Pharmacol Ther 2009; 30 (07) 749-756
- 22 D'Ugo S, Franceschilli L, Cadeddu F. et al. Medical and surgical treatment of haemorrhoids and anal fissure in Crohn's disease: a critical appraisal. BMC Gastroenterol 2013; 13 (01) 47
- 23 Wolkomir AF, Luchtefeld MA. Surgery for symptomatic hemorrhoids and anal fissures in Crohn's disease. Dis Colon Rectum 1993; 36 (06) 545-547
- 24 Bonheur JL, Braunstein J, Korelitz BI, Panagopoulos G. Anal skin tags in inflammatory bowel disease: new observations and a clinical review. Inflamm Bowel Dis 2008; 14 (09) 1236-1239
- 25 Williams DR, Coller JA, Corman ML, Nugent FW, Veidenheimer MC. Anal complications in Crohn's disease. Dis Colon Rectum 1981; 24 (01) 22-24
- 26 Singh B, McC Mortensen NJ, Jewell DP, George B, George MB. Perianal Crohn's disease. Br J Surg 2004; 91 (07) 801-814
- 27 Bouguen G, Siproudhis L, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Nonfistulizing perianal Crohn's disease: clinical features, epidemiology, and treatment. Inflamm Bowel Dis 2010; 16 (08) 1431-1442
- 28 Taylor BA, Williams GT, Hughes LE, Rhodes J. The histology of anal skin tags in Crohn's disease: an aid to confirmation of the diagnosis. Int J Colorectal Dis 1989; 4 (03) 197-199
- 29 Korelitz BI. Anal skin tags: an overlooked indicator of Crohn's disease. J Clin Gastroenterol 2010; 44 (02) 151-152
- 30 Korelitz BI, Partiula B, Teagle K. et al. Increasing pediatricians' awareness of the association between anal skin tags and earlier diagnosis of Crohn's disease. Inflamm Intest Dis 2018; 3 (01) 40-42
- 31 Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn's disease. Gastroenterology 2003; 125 (05) 1508-1530
- 32 McKenna NP, Lightner AL, Habermann EB, Mathis KL. Hemorrhoidectomy and excision of skin tags in IBD: Harbinger of doom or simply a disease running its course?. Dis Colon Rectum 2019; 62 (12) 1505-1511
- 33 Johanson JF, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterology 1990; 98 (02) 380-386
- 34 Jeffery PJ, Parks AG, Ritchie JK. Treatment of haemorrhoids in patients with inflammatory bowel disease. Lancet 1977; 1 (8021) 1084-1085
- 35 Cracco N, Zinicola R. Is haemorrhoidectomy in inflammatory bowel disease harmful? An old dogma re-examined. Colorectal Dis 2014; 16 (07) 516-519
- 36 Sanchez C, Chinn BT. Hemorrhoids. Clin Colon Rectal Surg 2011; 24 (01) 5-13
- 37 Lightner AL, Kearney D, Giugliano D. et al. Excisional hemorrhoidectomy: safe in patients with Crohn's disease?. Inflamm Bowel Dis 2020; 26 (09) 1390-1393
- 38 Wolff BG, Culp CE, Beart Jr RW, Ilstrup DM, Ready RL, Ready L. Anorectal Crohn's disease. A long-term perspective. Dis Colon Rectum 1985; 28 (10) 709-711
- 39 Brochard C, Siproudhis L, Wallenhorst T. et al. Anorectal stricture in 102 patients with Crohn's disease: natural history in the era of biologics. Aliment Pharmacol Ther 2014; 40 (07) 796-803
- 40 Lightner AL, Click B, Yamamoto T, Spinelli A, Kotze P. Management of isolated anal strictures in Crohn's disease. Dis Colon Rectum 2020; 63 (12) 1639-1647
- 41 Navaneethan U. Endoscopic stricturotomy for refractory anal strictures in Crohn's disease. Inflamm Bowel Dis 2020; 26 (09) e99-e100
- 42 Shen B, Kochhar G, Navaneethan U. et al; Global Interventional Inflammatory Bowel Disease Group. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group. Gastrointest Endosc 2019; 89 (02) 215-237
- 43 Atreja A, Aggarwal A, Dwivedi S. et al. Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn's disease strictures. J Crohns Colitis 2014; 8 (05) 392-400
- 44 Lan N, Shen B. Endoscopic stricturotomy with needle knife in the treatment of strictures from inflammatory bowel disease. Inflamm Bowel Dis 2017; 23 (04) 502-513
- 45 Linares L, Moreira LF, Andrews H, Allan RN, Alexander-Williams J, Keighley MRB. Natural history and treatment of anorectal strictures complicating Crohn's disease. Br J Surg 1988; 75 (07) 653-655
- 46 Bauer JJ, Gelernt IM, Salk BA, Kreel I. Proctectomy for inflammatory bowel disease. Am J Surg 1986; 151 (01) 157-162
- 47 Faye AS, Holmer AK, Axelrad JE. Cancer in inflammatory bowel disease. Gastroenterol Clin North Am 2022; 51 (03) 649-666
- 48 Slesser AAP, Bhangu A, Bower M, Goldin R, Tekkis PP. A systematic review of anal squamous cell carcinoma in inflammatory bowel disease. Surg Oncol 2013; 22 (04) 230-237
- 49 Beaugerie L, Carrat F, Nahon S. et al; Cancers et Surrisque Associé aux Maladies Inflammatoires Intestinales En France Study Group. High risk of anal and rectal cancer in patients with anal and/or perianal Crohn's disease. Clin Gastroenterol Hepatol 2018; 16 (06) 892-899.e2
- 50 Ruel J, Ko HM, Roda G. et al. Anal neoplasia in inflammatory bowel disease is associated with HPV and perianal disease. Clin Transl Gastroenterol 2016; 7 (03) e148
- 51 Johansen MP, Wewer MD, Nordholm-Carstensen A, Burisch J. Perianal Crohn's disease and the development of colorectal and anal cancer: a systematic review and meta-analysis. J Crohn's Colitis 2023; 17 (03) 361-368
- 52 Harpain F, Dawoud C, Wimmer K. et al. Fistula-associated anal adenocarcinoma: a 20-year single-center experience. Ann Surg Oncol 2023; 30 (06) 3517-3527
- 53 Sjödahl RI, Myrelid P, Söderholm JD. Anal and rectal cancer in Crohn's disease. Colorectal Dis 2003; 5 (05) 490-495
- 54 Albuquerque A, Cappello C, Stirrup O, Selinger CP. Anal high-risk human papillomavirus infection, squamous intraepithelial lesions, and anal cancer in patients with inflammatory bowel disease: a systematic review and meta-analysis. J Crohn's Colitis 2023; 17 (08) 1228-1234
- 55 Wong SY, Colombel JF. Cancer screening in patients with inflammatory bowel disease: don't forget the anus!. Inflamm Bowel Dis 2023; izad267
- 56 Iesalnieks I, Gaertner WB, Glass H. et al. Fistula-associated anal adenocarcinoma in Crohn's disease. Inflamm Bowel Dis 2010; 16 (10) 1643-1648
- 57 Yadav S, Singh S, Edakkanambeth Varayil J. et al. Hidradenitis suppurativa in patients with inflammatory bowel disease: a population-based cohort study in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2016; 14 (01) 65-70
- 58 Chen WT, Chi CC. Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis. JAMA Dermatol 2019; 155 (09) 1022-1027
- 59 Buchanan F, Saleem S, Alsamman MA. A Controversial relationship between Crohn's disease and Hidradenitis suppurativa: a case series and literature review. Cureus 2022; 14 (03) e23422
- 60 Amhis M, Belarbi KN, Bourrat E, Nassif A, Viala J, Martinez-Vinson C. Differential diagnosis between perianal Crohn's disease and Hidradenitis suppurativa: a challenging teamwork. JPGN Rep 2021; 2 (02) e081
- 61 Monnier L, Dohan A, Amara N. et al. Anoperineal disease in Hidradenitis suppurativa: MR imaging distinction from perianal Crohn's disease. Eur Radiol 2017; 27 (10) 4100-4109
- 62 Zhang M, Chen QD, Xu HX, Xu YM, Chen HJ, Yang BL. Association of hidradenitis suppurativa with Crohn's disease. World J Clin Cases 2021; 9 (15) 3506-3516
- 63 Giudici F, Maggi L, Santi R. et al. Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario. Clin Mol Allergy 2015; 13 (01) 12
- 64 Duerr RH, Taylor KD, Brant SR. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314 (5804) 1461-1463
- 65 Schlapbach C, Hänni T, Yawalkar N, Hunger RE. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol 2011; 65 (04) 790-798
- 66 Salvatori S, Marafini I, Monteleone G. Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature. Eur J Gastroenterol Hepatol 2021; 33 (1S, suppl 1): e1046-e1050